3,832 children diagnosed with leprosy as India targets interruption of transmission by 2027

The National Leprosy Eradication Programme (NLEP) operates as a Centrally Sponsored Scheme under the National Health Mission (NHM). Its primary goal is to achieve zero indigenous child cases for five consecutive years to interrupt transmission. The NLEP also aims for zero disability among new child cases and a national Grade-2 Disability (G2D) rate below 1 per million. However, the data highlights significant gaps in implementation, specifically concerning case detection. The detection of children with G2D, signaling delayed diagnosis, points to inadequate surveillance mechanisms and the persistent challenge of active case finding. Overcoming these hurdles requires strengthening household contact surveys, intensifying focused campaigns in endemic areas, and actively addressing the stigma associated with leprosy, which often discourages individuals from seeking early medical intervention.

Leprosy, caused by Mycobacterium leprae, carries a profound social burden. The disease disproportionately affects marginalized communities, particularly in states like Chhattisgarh, Jharkhand, Maharashtra, Odisha, and Madhya Pradesh, where prevalence remains high. The prolonged incubation period (averaging five years) combined with social stigma often leads to delayed presentation, resulting in visible deformities (Grade-2 Disability). These physical impairments further entrench the social exclusion and economic hardship faced by affected individuals and their families. Addressing the social determinants of health—such as poverty, overcrowding, and lack of awareness—is crucial for an effective eradication strategy. The persistence of new cases among children, particularly those with G2D, underscores the need for targeted social interventions that go beyond medical treatment to include community mobilization and stigma reduction programs.

From a public health perspective, the presence of new cases among children (under 15 years) is a vital epidemiological indicator of recent and active transmission within a community. According to the World Health Organization, India reported the largest number of new leprosy cases globally, highlighting a significant public health challenge. The cornerstone of public health management for leprosy is Multidrug Therapy (MDT), provided free of charge through public health programs. While MDT is highly effective in curing the infection, it cannot reverse established nerve damage. Therefore, early detection through active surveillance and contact tracing is paramount to prevent permanent disability. The fluctuating trends in child caseloads, especially during the COVID-19 pandemic, reflect disruptions in active case detection rather than true changes in disease transmission dynamics, highlighting the need for resilient and consistent public health surveillance systems.